Metabolomic analysis identifies differentially produced oral metabolites, including the oncometabolite 2-hydroxyglutarate, in patients with head and neck squamous cell carcinoma

by Cyrus Huneycutt | Nov 14, 2023 | 0 comments

Submit a Comment Cancel reply

You must be logged in to post a comment.